🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
dry eye disease after corneal collagen cross linking affect ocular function...
Status
Unknown
Location
INMC
Start Date
2021-02-01
Trial ID
NCT05045053
Treatments Being Tested
This is a multicenter, double-masked, randomized, parallel-group study with...
Status
Completed
Location
Eye Research Foundation
Start Date
2022-06-13
Trial ID
NCT05372107
Treatments Being Tested
Rationale and Aims: Infection by dengue virus (DENV) causes major morbidity...
Status
Unknown
Location
National University Hospital (Investigational Medicine Unit)
Start Date
2015-03
Trial ID
NCT02673840
This study evaluates the safety and efficacy of brimonidine 0.1% ophthalmic...
Status
Completed
Location
Multiple Locations
Start Date
2003-05
Trial ID
NCT00652483
Treatments Being Tested
To evaluate the ocular hypotensive efficacy and ocular and systemic safety ...
Status
Completed
Location
Aerie Pharmaceuticals
Start Date
2014-07
Trial ID
NCT02207491
Treatments Being Tested
To evaluate the benefit of treatment with a physician administered intracan...
Status
Terminated
Location
Eye Surgeons of Indiana
Start Date
2020-08-01
Trial ID
NCT04413253
Phase 3 study to evaluate the extended safety of RVL-1201 compared to place...
Status
Completed
Location
Barnet, Dulany Perkins
Start Date
2018-06-20
Trial ID
NCT03536949
Treatments Being Tested
The purpose of this study is to demonstrate superior intraocular pressure (...
Status
Completed
Location
Multiple Locations
Start Date
2013-12
Trial ID
NCT02003391
The purpose of this study is to determine the safety of Nevanac 0.1% compar...
Status
Completed
Location
Contact Alcon for Trial Locations
Start Date
2006-02
Trial ID
NCT00332774
The purpose of this study is to determine whether a homeopathic therapy in ...
Status
Terminated
Location
University of Missouri-Columbia, Mason Eye Institute
Start Date
2007-12
Trial ID
NCT01072526
Treatments Being Tested